TIVORBEX®: The lowest FDA-approved dose of indomethacin available (20 mg)
TIVORBEX is a nonsteroidal anti-inflammatory drug (NSAID) for patients with mild to moderate acute pain. Iroko Pharmaceuticals, LLC developed TIVORBEX to align with recommendations from FDA, medical organizations, and advocacy groups: Use the lowest NSAID dose possible for the shortest time needed for your treatment.
Do you know your NSAID dose?
Ask your doctor if you are taking the lowest dose possible for the treatment of mild to moderate acute pain. Then ask about TIVORBEX the low-dose SoluMatrix® indomethacin from Iroko.
TIVORBEX®: Possible side effects
Before beginning treatment with TIVORBEX, it is important to be aware of potential side effects and to discuss these potential problems with your doctor
- The most common side effects reported in clinical studies using TIVORBEX were nausea, localized swelling or bleeding at the site of surgery, headache, dizziness, vomiting, constipation, itching, diarrhea, heartburn, light-headedness, rash, stomach pain, drowsiness, excessive sweating, decreased appetite, hot flashes, and fainting
TIVORBEX®: Dosing and administration
TIVORBEX is FDA-approved at low doses of 20 mg (3 times daily) or 40 mg (twice or 3 times daily):
- In a clinical study, patients taking TIVORBEX had greater reductions in mild to moderate acute pain compared with patients who took placebo